Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY Display this book on your site! Related Titles New Vaccine Development:Establishing Priorities: Volume II, Diseases of Importance in Developing Countries Vaccines for the 21st Century: A Tool for Decisionmaking Other Related Titles New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States (1985) Board on Population Health and Public Health Practice (BPH) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix R: Technical Notes." New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States. Washington, DC: The National Academies Press, 1985. Please select a format: Page 444   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendix R TECHNICAL NOTES The calculations described in Chapters 4, 7, and 9 were conducted using the MULTIPLAN© spread sheet program, Version 1 (Microsoft Corporation, 10700 Northup Way, Bellevue, WA 98004), run on an IBM Personal Computer (International Business Machines, Boca Raton, FL 33432). The program requires 64K of memory. Inquiries regarding templates for these calculations for use with the MULTIPLAN© program should be directed to: Director Division of Health Promotion and Disease Prevention Institute of Medicine National Academy of Sciences 2101 Constitution Avenue, N.W. Washington, D.C. 20418 Use of the MULTIPLAN© program or the IBM Personal Computer do not constitute endorsement by the Institute of Medicine or the National Academy of Sciences. ©Microsoft Corporation, Bellevue, Wash. Page 444 Front Matter (R1-R14) 1. Summary (1-16) 2. Priority Setting for Health Related Investments: A Review of Methods (17-27) 3. Overview of the Analytic Approach (28-38) 4. Comparison of Disease Burdens and Costs (39-58) 5. Predictions on Vaccine Development (59-66) 6. Assessing the Likely Utilization of New Vaccines (67-91) 7. Calculation and Comparison of the Health Benefits and Costs Associated with Candidate Vaccines (92-120) 8. Additional Issues in the Selection of Priorities for Accelerated Vaccine Development (121-126) 9. Findings, Conclusions, and Recommendations (127-148) Appendix A: Some Examples of the Application of Project Selection Method (149-152) Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate (153-170) Appendix C: Prospects for Immunizing Against Bordetella pertussis (171-182) Appendix D: Prospects for Immunizing Against Coccidioidomycosis (183-197) Appendix E: Prospects for Immunizing Against Cytomegalovirus (198-234) Appendix F: Prospects for Immunizing Against Hemophilus influenzae type b (235-251) Appendix G: Prospects for Immunizing Against Hepatitis A Virus (252-260) Appendix H: Prospects for Immunizing Against Hepatitis B Virus (261-279) Appendix I: Prospects for Immunizing Against Herpes Simplex Viruses 1 and 2 (280-312) Appendix J: Prospects for Immunizing Against Herpesvirus varicellae (313-341) Appendix K: Prospects for Immunizing Against Influenza Viruses A and B (342-364) Appendix L: Prospects for Immunizing Against Neisseria gonorrhoeae (365-384) Appendix M: Prospects for Immunizing Against Parainfluenza Viruses (385-396) Appendix N: Prospects for Immunizing Against Respiratory Syncytial Virus (397-409) Appendix O: Prospects for Immunizing Against Rotavirus (410-423) Appendix P: Prospects for Immunizing Against Streptococcus group B (424-439) Appendix Q: Questionnaire for Assessing Morbidity-Mortality Trade-Offs (440-443) Appendix R: Technical Notes (444-444) Appendix S: Biographical Notes on Committee Members (445-449) Appendix T: Additional Sources of Advice to the Committee (450-452) Index (453-458)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 444